by ComplianceQuest
My Dashboard
Inspection Tracker
FDA Guidance
Templates
Assessments
Sign in
Get started
Tracker Overview
Enforcement Themes
Form 483s
Warning Letters
Inspections
Recalls
Investigators
Companies
Facilities
Loading…
Dashboard
Warning Letters
Warning Letter Details
Xiamen Kang Zhongyuan Biotechnology Co., Ltd. Warning Letter Details
Warning Letter
Watch this company
View Letter
Overview
Violations
Related Form 483s
Related Inspections
1
Xiamen Kang Zhongyuan Biotechnology Co., Ltd.
Xiamen Kang Zhongyuan Biotechnology Co., Ltd., No. 2018-2, Jietou Road Xiang'an Qu Xiamen Shi Fujian Sheng , 361101 China
Issue Date
March 23, 2026
FEI Number
3027976266
Violations
3
Country
China
Issuing Office
Center for Drug Evaluation and Research (CDER)
Product Type
Drugs
Status
Open
Subject
CGMP/Finished Pharmaceuticals/Adulterated
Xiamen Kang Zhongyuan Biotechnology Co., Ltd. FDA Warning Letter, March 23, 2026
